World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
25511
World Ranking
13265
National Ranking
708

Overview

Manfred Schmitt was affiliated with the Technical University of Munich in Germany. Their research spanned multiple disciplines with a strong focus on psychology, social sciences, and biochemistry, genetics, and molecular biology.

The scientist's main fields of study included:

  • Psychology
  • Social Sciences
  • Biochemistry, Genetics and Molecular Biology

Within these fields, Schmitt contributed to several subfields, notably:

  • Experimental and Cognitive Psychology
  • Sociology and Political Science
  • Molecular Biology
  • Clinical Psychology
  • Social Psychology

The work covered topics categorized under:

  • Social and Intergroup Psychology
  • Mental Health Research Topics
  • Behavioral Health and Interventions
  • Personality Traits and Psychology
  • Environmental Education and Sustainability
  • Environmental Sustainability in Business
  • Cognitive Abilities and Testing

Schmitt's publication record included frequent contributions to the following venues:

  • mSphere
  • Social Psychological and Personality Science
  • Psychologische Rundschau
  • Verhaltenstherapie
  • Sustainability

Several notable recent papers from the scientist include:

  • REMOTE SENSING IMAGE CLASSIFICATION WITH THE SEN12MS DATASET, 2021, ISPRS annals of the photogrammetry, remote sensing and spatial information sciences
  • A Multilab Replication of the Ego Depletion Effect, 2020, Social Psychological and Personality Science
  • Plastic-Free July: An Experimental Study of Limiting and Promoting Factors in Encouraging a Reduction of Single-Use Plastic Consumption, 2020, Sustainability
  • Exploring the psychological antecedents of private and public sphere behaviours to reduce household plastic consumption, 2022, Environment Development and Sustainability
  • Cell-type-specific differences in KDEL receptor clustering in mammalian cells, 2020, PLoS ONE

Schmitt collaborated frequently with several coauthors, with whom they had multiple joint publications:

  • Anna Baumert
  • Axel Zinkernagel
  • Susanne Weis
  • Tanja Lischetzke
  • Björn Becker

Best Publications

  • Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

    Maxime P. Look;Wim L. J. van Putten;Michael J. Duffy;Nadia Harbeck

  • BCR-ABL Maintains Resistance of Chronic Myelogenous Leukemia Cells to Apoptotic Cell Death

    Anne McGahon;Reid Bissonnette;Reid Bissonnette;Manfred Schmitt;Manfred Schmitt;Kate M. Cotter;Kate M. Cotter

  • Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

    F. Janicke;A. Prechtl;C. Thomssen;N. Harbeck

  • The Urokinase System of Plasminogen Activation and Prognosis in 2780 Breast Cancer Patients

    J. A. Foekens;H. A. Peters;M. P. Look;H. Portengen

  • Increased Neutrophil-Platelet Adhesion in Patients With Unstable Angina

    I Ott;F J Neumann;M Gawaz;M Schmitt

  • Clinical impact of the plasminogen activation system in tumor invasion and metastasis : Prognostic relevance and target for therapy

    M Schmitt;N Harbeck;C Thomssen;O Wilhelm

  • Increased Expression of Matrix Metalloproteinases (MMP)-2, MMP-9, and the Urokinase-Type Plasminogen Activator Is Associated with Progression from Benign to Advanced Ovarian Cancer

    Barbara Schmalfeldt;Dieter Prechtel;Kathrin Härting;Kerstin Späthe

  • Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier.

    Hans-Joachim Stemmler;Manfred Schmitt;Amina Willems;Helga Bernhard

  • Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

    Fritz Jänicke;Manfred Schmitt;Lothar Pache;Kurt Ulm

  • Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).

    H Kobayashi;M Schmitt;L Goretzki;N Chucholowski

  • Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer

    John A. Foekens;David Atkins;Yi Zhang;Fred C.G.J. Sweep

  • A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire

    Nadia Saucedo-Zeni;Steffi Mewes;Robert Niestroj;Lukasz Gasiorowski

  • Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.

    Johannes Bange;Dieter Prechtl;Yuri Cheburkin;Katja Specht

  • Yeast viral killer toxins: lethality and self-protection

    Manfred J. Schmitt;Frank Breinig

  • Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer.

    Fritz Jänicke;Manfred Schmitt;Henner Graeff

  • Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry.

    Sandra Rauser;Claudio Marquardt;Benjamin Balluff;Sören-Oliver Deininger

  • Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.

    J. A. Foekens;M. Schmitt;W. L. J. Van Putten;H. A. Peters

  • uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies.

    Michael J Duffy;Patricia M McGowan;Nadia Harbeck;Christoph Thomssen

  • Prognostic Impact of Urokinase-type Plasminogen Activator and Its Inhibitor PAI-1 in Completely Resected Gastric Cancer

    Hjalmar Nekarda;Manfred Schmitt;Kurt Ulm;Andrea Wenninger

  • Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).

    Nadia Harbeck;Ronald E. Kates;Maxime P. Look;Marion E. Meijer-van Gelder

Frequent Co-Authors

Viktor Magdolen
Viktor Magdolen Technical University of Munich
Nadia Harbeck
Nadia Harbeck Ludwig-Maximilians-Universität München
Heinz Höfler
Heinz Höfler Technical University of Munich
John A. Foekens
John A. Foekens Erasmus University Rotterdam
Fred C.G.J. Sweep
Fred C.G.J. Sweep Radboud University
Eleftherios P. Diamandis
Eleftherios P. Diamandis Mount Sinai Hospital
Horst Kessler
Horst Kessler Technical University of Munich
Christoph Thomssen
Christoph Thomssen University of Göttingen
Nils Brünner
Nils Brünner University of Copenhagen
Andreas Scorilas
Andreas Scorilas National and Kapodistrian University of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine opens doors to various related online degrees and alternative pathways in healthcare. Many students seek roles in administration, informatics, or pharmacy, often complementing or expanding their medical expertise.

For those interested in the business side of healthcare, exploring affordable mha online programs can help you develop leadership and management skills needed for hospital administration.

Nurses looking to advance can consider the most affordable dnp programs to earn a Doctor of Nursing Practice, focusing on clinical expertise and healthcare policy.

If you are interested in pharmacy, choosing the best online pharmacy school allows you to pursue a flexible doctorate, preparing for careers in clinical pharmacy, research, or industry.

Additionally, degrees in health informatics blend technology with healthcare, offering opportunities in data analysis, records management, and healthcare IT.

All these online degrees present cost-effective routes to enter or advance within the robust healthcare field.

Best Scientists Citing Manfred Schmitt

Recently Published Articles